Identification, Next-Generation Sequencing (Bill Only)
Use
This test is designed for billing purposes only and is not orderable as a standalone clinical test. It is associated with identification processes utilizing next-generation sequencing techniques, which are advanced methodologies for detecting genetic variants, offering comprehensive analysis applicable in research settings or as part of larger clinical study arrays.
Special Instructions
The test, labeled as 'Not Orderable', serves billing functions rather than direct diagnostic purposes, indicating it might be part of a broader service that includes next-generation sequencing as a part of its methodology. NY State approval is confirmed, but practical application is under specific conditions likely tied to broader, comprehensive genomic panels used internally within clinical or research frameworks.
Limitations
The 'Identification, Next-Generation Sequencing' test is a support service for broader panels and not intended for individual diagnostic use, it thus lacks independent interpretive and clinical reporting. As a non-orderable test, limitations include the inability to be directly requested by practitioners or patients and absence of standalone clinical interpretive data, restricting utility to internal institutional processes or specific research study frameworks where it contributes supplementary genomic data insights.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided